(Q46579180)

23 December 2017

title

Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya (English)

1 reference

23 December 2017

0 references

1 reference

1

Daniel R Feikin

1 reference

23 December 2017

12

Robert F Breiman

1 reference

23 December 2017

10

Max Ciarlet

1 reference

23 December 2017

Kathleen Neuzil

11

object named as

Kathleen M Neuzil

1 reference

23 December 2017

Kayla Laserson

2

object named as

Kayla F Laserson

1 reference

23 December 2017

author name string

Joel Ojwando

3

1 reference

23 December 2017

Geoffrey Nyambane

4

1 reference

23 December 2017

Victor Ssempijja

5

1 reference

23 December 2017

Allan Audi

6

1 reference

23 December 2017

Daveline Nyakundi

7

1 reference

23 December 2017

Janet Oyieko

8

1 reference

23 December 2017

Michael J Dallas

9

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

23 December 2017

published in

Vaccine

1 reference

23 December 2017

volume

30 Suppl 1

1 reference

23 December 2017

page(s)

A52-60

1 reference

23 December 2017

Global, regional, and national causes of child mortality in 2008: a systematic analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Estimating child mortality due to diarrhoea in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Global mortality associated with rotavirus disease among children in 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Health and demographic surveillance in rural western Kenya: a platform for evaluating interventions to reduce morbidity and mortality from infectious diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Comparison of seven kits for detection of rotavirus in fecal specimens with a sensitive, specific enzyme immunoassay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Burden and Epidemiology of Rotavirus Diarrhea in Selected African Countries: Preliminary Results from the African Rotavirus Surveillance Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Healthcare-seeking behaviour for common infectious disease-related illnesses in rural Kenya: a community-based house-to-house survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

A 10 year study of the cause of death in children under 15 years in Manhiça, Mozambique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Determinants of health care seeking for childhood illnesses in Nairobi slums

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Prevalence and factors associated with rotavirus infection among children admitted with acute diarrhea in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Diarrhea in children less than two years of age with known HIV status in Kisumu, Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Rotavirus infection in infants as protection against subsequent infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Immunogenicity of the pentavalent rotavirus vaccine in African infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Oral rotavirus vaccines: how well will they work where they are needed most?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.043

10.1016/J.VACCINE.2011.08.043

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017